Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.020
-0.120 (-10.53%)
At close: Mar 9, 2026, 4:00 PM EDT
1.020
0.00 (0.02%)
After-hours: Mar 9, 2026, 5:09 PM EDT
Clearmind Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| Market Capitalization | 2 | 4 | 6 | 2 | 10 | 22 | |
| Market Cap Growth | -67.37% | -22.88% | 216.02% | -82.88% | -53.16% | - | |
| Enterprise Value | -2 | 1 | -2 | -2 | 10 | 17 | |
| Last Close Price | 1.14 | 31.82 | 55.60 | 146.28 | 9480.01 | 21344.46 | |
| PB Ratio | 0.15 | 3.65 | 1.81 | 1.81 | -9.42 | 5.74 | |
| P/TBV Ratio | 1.75 | 3.97 | 1.88 | 2.07 | - | 5.99 | |
| Debt / Equity Ratio | 1.49 | 1.49 | 0.02 | - | -0.04 | - | |
| Net Debt / Equity Ratio | -3.19 | -3.19 | -2.19 | -5.61 | 0.26 | -0.96 | |
| Net Debt / EBITDA Ratio | 0.67 | 0.67 | 1.19 | 0.88 | 0.05 | 1.25 | |
| Net Debt / FCF Ratio | 0.80 | 0.80 | 1.40 | 0.88 | 0.08 | 1.60 | |
| Quick Ratio | 1.21 | 1.21 | 1.71 | 1.16 | 0.22 | 13.33 | |
| Current Ratio | 1.22 | 1.22 | 1.72 | 1.17 | 0.23 | 13.78 | |
| Return on Equity (ROE) | -179.39% | -179.39% | -256.89% | - | -570.96% | -145.26% | |
| Return on Assets (ROA) | -53.11% | -53.11% | -54.37% | -116.22% | -169.53% | -83.90% | |
| Return on Capital Employed (ROCE) | -475.20% | -475.20% | -183.90% | -640.90% | 565.20% | -76.80% | |
| Earnings Yield | -200.84% | -88.70% | -93.20% | -483.18% | -66.18% | -13.49% | |
| FCF Yield | -246.53% | -108.88% | -86.17% | -353.19% | -35.80% | -10.40% | |
| Buyback Yield / Dilution | -63.98% | -63.98% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.